市場調查報告書

失眠症治療藥的全球市場(2020年∼2026年)

Global Insomnia Treatment Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949491
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
失眠症治療藥的全球市場(2020年∼2026年) Global Insomnia Treatment Market 2020-2026
出版日期: 2020年06月01日內容資訊: 英文
簡介

全球失眠症治療藥市場,預計在預測期間內大幅度成長。促進該市場成長的主要原因,是人們之間的壓力等級增加,失眠症的病例增加,失眠症治療藥的可用性相關認識的高漲。再加上各種醫藥品的銷售和複數學名藥的可得性預計促進市場成長。

本報告提供全球失眠症治療藥市場的相關調查,市場趨勢和機會,成長及阻礙因素,各類型、銷售管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 法律規章

第3章 競爭情形

  • 主要策略分析
  • 主要企業分析
    • Pfizer Inc.
    • Sanofi SA
    • Merck & Co. Inc.
    • 武田藥品工業株式會社
    • Boehringer Ingelheim International GmbH

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各類型
    • 藥物
    • 設備
  • 各銷售管道
    • 處方
    • 商店(OTC)

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Arena Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Eisai Co. Ltd.
  • Electromedical Products International Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Mallinckrodt LLC
  • Merck & Co. Inc.
  • Mylan N.V.
  • Natrol, LLC
  • Paratek Pharmaceuticals Inc.
  • Pfizer Inc.
  • Sanofi SA
  • 大日本住友製藥株式會社
  • 武田藥品工業株式會社
  • Teva Pharmaceutical Industries Ltd.
  • Vanda Pharmaceuticals Inc.
目錄
Product Code: OMR2021810

Global Insomnia Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antidepressant, Benzodiazepine, Nonbenzodiazepine, Melatonin Receptor Agonist, Orexin Antagonist, and Others), and Devices), and by Sales Channels (Prescription and Over-the-Counter (OTC)), and Forecast 2020-2026

The global insomnia treatment market is projected to grow significantly during the forecast period. The key aspects that drive the growth of the market include the increased levels of stress among the peoples, increased cases of insomnia, and rising awareness regarding the availability of treatment of insomnia. Moreover, the launch of various drugs and the availability of multiple generics is anticipated to enhance the growth of the market. For instance, in December 2019, the US FDA approved the Eisai's drug named Lemborexant, a novel Orexin Receptor Antagonist (ORA) for the treatment of insomnia.

The global insomnia treatment market is segmented on the basis of type and sales channels. Based on the type, the market is segmented into drugs and devices. The drugs segment is projected to hold a significant share in the market. Drugs segment is further divided into antidepressants, benzodiazepine, nonbenzodiazepine, melatonin receptor agonist, orexin antagonist, and others. Based on the sales channels, the market is segmented as prescription, and over-the-counter (OTC). The prescription segment is likely to contribute significantly to the market growth during the forecast period.

Geographically, the study of the global insomnia treatment market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global insomnia treatment market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Further, Arena Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Co., Merck & Co. Inc., Mylan N.V., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and others are some of the prominent players operating in the global insomnia treatment market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.

Research Methodology

The market study of the global insomnia treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for insomnia treatment market players, drug manufacturing companies, investment companies, industry associations & experts, research institutes, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Insomnia Treatment Market Research and Analysis by Type

2. Global Insomnia Treatment Market Research and Analysis by Sales Channel

The Report Covers:

  • Comprehensive research methodology of the global insomnia treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global insomnia treatment market.
  • Insights about market determinants which are stimulating the global insomnia treatment market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Pfizer Inc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. Sanofi SA
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Merck & Co. Inc.
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. Takeda Pharmaceuticals Co. Ltd.
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments
    • 3.2.5. Boehringer Ingelheim International GmbH
      • 3.2.5.1. Overview
      • 3.2.5.2. Financial Analysis
      • 3.2.5.3. SWOT Analysis
      • 3.2.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Insomnia Treatment Market by Type
    • 5.1.1. Drugs
      • 5.1.1.1. Antidepressants
      • 5.1.1.2. Benzodiazepine
      • 5.1.1.3. Nonbenzodiazepine
      • 5.1.1.4. Melatonin Receptor Agonist
      • 5.1.1.5. Orexin Antagonist
      • 5.1.1.6. Others
    • 5.1.2. Devices
  • 5.2. Global Insomnia Treatment Market by Sales Channels
    • 5.2.1. Prescription
    • 5.2.2. Over-the-Counter (OTC)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Arena Pharmaceuticals, Inc.
  • 7.2. Boehringer Ingelheim International GmbH
  • 7.3. Eisai Co. Ltd.
  • 7.4. Electromedical Products International Inc.
  • 7.5. Eli Lilly and Co.
  • 7.6. GlaxoSmithKline Plc
  • 7.7. Mallinckrodt LLC
  • 7.8. Merck & Co. Inc.
  • 7.9. Mylan N.V.
  • 7.10. Natrol, LLC
  • 7.11. Paratek Pharmaceuticals Inc.
  • 7.12. Pfizer Inc.
  • 7.13. Sanofi SA
  • 7.14. Sumitomo Dainippon Pharma Co. Ltd.
  • 7.15. Takeda Pharmaceutical Co. Ltd.
  • 7.16. Teva Pharmaceutical Industries Ltd.
  • 7.17. Vanda Pharmaceuticals Inc.

LIST OF TABLES

  • 1. GLOBAL INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL INSOMNIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL ANTIDEPRESSANT DRUGS FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL BENZODIAZEPINE DRUGS FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL NONBENZODIAZEPINE DRUGS FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL MELATONIN RECEPTOR AGONIST DRUGS FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL OREXIN ANTAGONIST DRUGS FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL OTHER DRUGS FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL DEVICES FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 10. GLOBAL INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2019-2026 ($ MILLION)
  • 11. GLOBAL PRESCRIPTION TREATMENT FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL OVER-THE-COUNTER (OTC) TREATMENT FOR INSOMNIA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 13. GLOBAL INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 16. NORTH AMERICAN INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2019-2026 ($ MILLION)
  • 17. EUROPEAN INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 18. EUROPEAN INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 19. EUROPEAN INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2019-2026 ($ MILLION)
  • 20. ASIA-PACIFIC INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 21. ASIA-PACIFIC INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 22. ASIA-PACIFIC INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2019-2026 ($ MILLION)
  • 23. REST OF THE WORLD INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 24. REST OF THE WORLD INSOMNIA TREATMENT MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INSOMNIA TREATMENT MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL INSOMNIA TREATMENT MARKET SHARE BY SALES CHANNEL, 2019 VS 2026 (%)
  • 3. GLOBAL INSOMNIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD INSOMNIA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)